Pharmaceutical companies in the limelight

Much-awaited: Malaysia will receive one million doses from Pfizer in Q1 2021,1.7 million doses in Q2,5.8 million doses in Q3 and 4.3 million doses in Q4. — AP

PHARMACEUTICAL companies continue to enjoy investor attention on increasing Covid-19 vaccine hopes and the positive newsbytes have turbo-charged the industry.

Pharmaniaga (pic below) has appreciated some 127% since it was identified by the Government for the fill-and-finish work of the vaccine in July 2020. In the past five days, the counter has gained 5% to RM5.25.